Indonesia · Delayed Price · Currency is IDR PT Kimia Farma Tbk Statistics
Total Valuation
IDX:KAEF has a market cap or net worth of IDR 1.88 trillion. The enterprise value is 8.76 trillion.
| Market Cap | 1.88T |
| Enterprise Value | 8.76T |
Important Dates
The next estimated earnings date is Friday, November 6, 2026.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:KAEF has 5.57 billion shares outstanding.
| Current Share Class | 5.57B |
| Shares Outstanding | 5.57B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.43% |
| Float | 566.59M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | 24.43 |
| P/OCF Ratio | 14.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.68, with an EV/FCF ratio of 113.70.
| EV / Earnings | n/a |
| EV / Sales | 0.94 |
| EV / EBITDA | 16.68 |
| EV / EBIT | n/a |
| EV / FCF | 113.70 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 2.59.
| Current Ratio | 1.04 |
| Quick Ratio | 0.41 |
| Debt / Equity | 2.59 |
| Debt / EBITDA | 13.47 |
| Debt / FCF | 91.81 |
| Interest Coverage | 0.01 |
Financial Efficiency
Return on equity (ROE) is -7.50% and return on invested capital (ROIC) is -0.48%.
| Return on Equity (ROE) | -7.50% |
| Return on Assets (ROA) | 0.04% |
| Return on Invested Capital (ROIC) | -0.48% |
| Return on Capital Employed (ROCE) | 0.08% |
| Weighted Average Cost of Capital (WACC) | 7.22% |
| Revenue Per Employee | 992.49M |
| Profits Per Employee | -23.21M |
| Employee Count | 9,361 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 4.30 |
Taxes
In the past 12 months, IDX:KAEF has paid 8.68 billion in taxes.
| Income Tax | 8.68B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.59% in the last 52 weeks. The beta is 1.05, so IDX:KAEF's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -44.59% |
| 50-Day Moving Average | 417.70 |
| 200-Day Moving Average | 469.59 |
| Relative Strength Index (RSI) | 30.61 |
| Average Volume (20 Days) | 983,200 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:KAEF had revenue of IDR 9.29 trillion and -217.24 billion in losses.
| Revenue | 9.29T |
| Gross Profit | 2.94T |
| Operating Income | 8.53B |
| Pretax Income | -213.47B |
| Net Income | -217.24B |
| EBITDA | 387.69B |
| EBIT | 8.53B |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 467.62 billion in cash and 7.07 trillion in debt, with a net cash position of -6,603.45 billion or -1,186.27 per share.
| Cash & Cash Equivalents | 467.62B |
| Total Debt | 7.07T |
| Net Cash | -6,603.45B |
| Net Cash Per Share | -1,186.27 |
| Equity (Book Value) | 2.73T |
| Book Value Per Share | n/a |
| Working Capital | 199.26B |
Cash Flow
In the last 12 months, operating cash flow was 128.47 billion and capital expenditures -51.45 billion, giving a free cash flow of 77.02 billion.
| Operating Cash Flow | 128.47B |
| Capital Expenditures | -51.45B |
| Depreciation & Amortization | 373.46B |
| Net Borrowing | -62.04B |
| Free Cash Flow | 77.02B |
| FCF Per Share | 13.84 |
Margins
Gross margin is 31.65%, with operating and profit margins of 0.09% and -2.34%.
| Gross Margin | 31.65% |
| Operating Margin | 0.09% |
| Pretax Margin | -2.30% |
| Profit Margin | -2.34% |
| EBITDA Margin | 4.17% |
| EBIT Margin | 0.09% |
| FCF Margin | 0.81% |
Dividends & Yields
IDX:KAEF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -11.55% |
| FCF Yield | 4.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |